MD Anderson Cancer Center is a leading global cancer treatment and research institution located in Houston, Texas, United States. It is affiliated with the University of Texas system and has been rated as a cancer specialty hospital by U.S. News&World Report for several consecutive years. The center features a multidisciplinary diagnosis and treatment model (MDT), bringing together experts in oncology, radiology, pathology, and surgery to tailor personalized treatment plans for patients. MD Anderson is renowned for its innovative capabilities in cutting-edge technologies such as immunotherapy, targeted therapy, gene testing, and proton therapy, while continuously driving the forefront of cancer treatment through thousands of clinical trials. In addition, MD Anderson's research team operates over 200 laboratories focused on basic research and clinical applications of cancer, providing patients with better experimental treatment options and significantly improving the likelihood of cancer being cured.

Every year, MD Anderson Cancer Center receives patients from over 120 countries worldwide. Its international patient center provides a full process service covering medical record evaluation, expert appointments, treatment arrangements, and rehabilitation follow-up, and is equipped with a professional multilingual medical team to ensure barrier free cross-cultural communication. The center is not only renowned for its excellent medical technology, but also adheres to the patient-centered service philosophy, providing a comfortable treatment environment and psychological support services to help patients and their families cope with the challenges of cancer treatment. From technological leadership to humanistic care, MD Anderson has always been committed to providing patients with better treatment and thoughtful support, making it the preferred place for cancer patients worldwide to seek hope.